We Won a Delay on OMB Guidance, Tell Congress to Finish the Job
Today, we’re saying a big thank you to our Members of Congress. By passing a continuing resolution that delays the proposed Office of Management and Budget (OMB) “Regulation for Federal […]
This Week in “What’s New in ME/CFS?” Dr. Avik Roy & Dr. Gunnar Gottschalk (Simmaron Research)
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we can do about this disease. Recently, we spoke with Dr. Avik Roy, Chief Scientific Officer at Simmaron […]
Patient Feedback Spurs Expansion of ADDRESS-LC Trial: More Test Sites, Broader Enrollment
In July, Solve hosted a webinar featuring representatives of the ADDRESS-LC Trial, which was designed to assess the potential impact of the drug bezisterim on cognitive impairment/brain fog and fatigue […]
Watch! The ADDRESS-LC Trial Webinar
The ADDRESS-LC trial was designed to assess the potential impact of bezisterim on cognitive impairment/brain fog and fatigue in individuals with Long Covid and is currently recruiting people aged 18-64 […]
Help Advance Science—Find a Clinical Study That Needs You
Are you interested in learning more about current clinical trials for ME/CFS, Long Covid, and associated conditions? We’ve launched a new webpage listing US-based clinical trials that are recruiting or […]
The ADDRESS-LC Trial: Studying the Impact of Bezisterim on Brain fog and Fatigue in People with Long Covid
In this webinar, we’ll be joined by panelists Michael Peluso, MD (Assistant Professor of Medicine, University of California, San Francisco) Ezra Spier (Creator, Long Covid Studies), Penelope Markham, PhD (Senior […]
Solve Selects Simmaron Research As Recipient of ME/CFS Catalyst Award to Accelerate Low-Dose Rapamycin Trial for ME/CFS, Long COVID, and IACCs
Dr. C. Gunnar Gottschalk and Dr. Avik Roy Solve M.E. is proud to announce that we’ve selected the Simmaron Research Institute as the winner of our second Solve ME/CFS Catalyst […]
New Clinical Trial Will Test How Baricitinib Improves Neurocognitive Function in Patients with Long Covid
People with Long Covid may participate in an important new clinical trial—the REVERSE-LC trial (Evaluating Baricitinib on Persistent Neurologic and Cardiopulmonary Symptoms of Long COVID)—which will test whether the drug […]
The RECOVER-TLC Event Day Two: Prioritization of Interventions, Study Design, and End Points
In 2021, the National Institutes of Health (NIH) launched its ambitious nearly $2 billion RECOVER Initiative, dedicated to finding the root causes of and possible treatments for Long Covid. Solve played […]
Solve Advocacy Efforts Yield Another Victory!
Solve Advocacy Efforts Yield Another Victory! CDMRP Program at Department of Defense Announces $13.1M Grant for Long Covid Research Solve is dedicated to opening new funding avenues for ME/CFS, Long Covid, […]
Join a Hydrogen Water Dosing Clinical Trial for ME/CFS
Are you impacted by ME/CFS and want to help advance our understanding of the disease? Dr. Fred Friedberg (Research Professor at Stony Brook University School of Medicine) is recruiting for […]
Webinar: Hydrogen Water Dosing Study for ME/CFS: A New Clinical Trial
Free radicals are molecules with one or more unpaired electrons in their outer shells. They tear holes in cell membranes, releasing an overabundance of even more free radicals and preventing […]